KR101514860B1 - 세사민류 및 퀘르세틴 배당체를 함유하는 조성물 - Google Patents

세사민류 및 퀘르세틴 배당체를 함유하는 조성물 Download PDF

Info

Publication number
KR101514860B1
KR101514860B1 KR1020107016435A KR20107016435A KR101514860B1 KR 101514860 B1 KR101514860 B1 KR 101514860B1 KR 1020107016435 A KR1020107016435 A KR 1020107016435A KR 20107016435 A KR20107016435 A KR 20107016435A KR 101514860 B1 KR101514860 B1 KR 101514860B1
Authority
KR
South Korea
Prior art keywords
sesamin
quercetin
glycoside
absorption
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020107016435A
Other languages
English (en)
Korean (ko)
Other versions
KR20100103849A (ko
Inventor
나미노 도미모리
요시코 오노
Original Assignee
산토리 홀딩스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 산토리 홀딩스 가부시키가이샤 filed Critical 산토리 홀딩스 가부시키가이샤
Publication of KR20100103849A publication Critical patent/KR20100103849A/ko
Application granted granted Critical
Publication of KR101514860B1 publication Critical patent/KR101514860B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR1020107016435A 2007-12-28 2008-12-19 세사민류 및 퀘르세틴 배당체를 함유하는 조성물 Expired - Fee Related KR101514860B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2007-338853 2007-12-28
JP2007338853A JP5276316B2 (ja) 2007-12-28 2007-12-28 セサミン類及びケルセチン配糖体を含有する組成物
PCT/JP2008/073206 WO2009084482A1 (ja) 2007-12-28 2008-12-19 セサミン類及びケルセチン配糖体を含有する組成物

Publications (2)

Publication Number Publication Date
KR20100103849A KR20100103849A (ko) 2010-09-28
KR101514860B1 true KR101514860B1 (ko) 2015-04-23

Family

ID=40824199

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107016435A Expired - Fee Related KR101514860B1 (ko) 2007-12-28 2008-12-19 세사민류 및 퀘르세틴 배당체를 함유하는 조성물

Country Status (11)

Country Link
US (1) US8653040B2 (enExample)
JP (1) JP5276316B2 (enExample)
KR (1) KR101514860B1 (enExample)
CN (1) CN101909619B (enExample)
AU (1) AU2008344481B2 (enExample)
CA (1) CA2710379C (enExample)
MY (1) MY153899A (enExample)
NZ (1) NZ586196A (enExample)
SG (1) SG187399A1 (enExample)
TW (1) TWI429430B (enExample)
WO (1) WO2009084482A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109705178A (zh) * 2018-12-28 2019-05-03 贵阳中医学院 一种从小花清风藤中提取的化合物及其提取工艺和应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2470157A1 (en) * 2009-08-24 2012-07-04 The Board of Governors for Higher Education, State of Rhode Island and Providence Plantations Hot-melt extruded compositions containing plant-derived phenolic materials and processes for the preparation thereof
JP2015030690A (ja) * 2013-08-01 2015-02-16 東洋精糖株式会社 プテリジン誘導体の生体吸収性が向上した組成物および生体吸収促進剤
CN103977015B (zh) * 2014-05-05 2016-10-05 南京瑞菁医药科技有限责任公司 中药毛菊苣降脂活性成分配伍组合物
CN107405329B (zh) * 2015-03-23 2021-04-09 三得利控股株式会社 昼夜节律改善用组合物
JP2019014697A (ja) * 2017-07-11 2019-01-31 株式会社アンチエイジング・プロ ポリフェノール吸収促進用組成物、ポリフェノール体内吸収性向上方法、及び経口摂取用組成物
WO2021006822A1 (en) * 2019-07-08 2021-01-14 Chiangmai University Pharmaceutical compositions having synergistic effects of natural extracts for cancer treatment undergoing chemotherapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006014028A1 (ja) 2004-08-06 2006-02-09 Mochida Pharmaceutical Co., Ltd. サツマイモ茎葉抽出物およびその用途
WO2006070856A1 (ja) 2004-12-28 2006-07-06 Suntory Limited セサミン／エピセサミン組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0558902A (ja) * 1991-08-30 1993-03-09 Nippon Oil & Fats Co Ltd アレルギー予防油脂組成物
JPH10273444A (ja) * 1997-03-28 1998-10-13 Tama Seikagaku Kk イチョウエキスの製造方法
JP4205188B2 (ja) * 1997-10-01 2009-01-07 一丸ファルコス株式会社 メイラード反応阻害剤
JP2007137775A (ja) * 2005-11-15 2007-06-07 Kaneka Corp 破骨細胞分化抑制因子（ｏｐｇ）産生促進用組成物
JP4579885B2 (ja) * 2006-09-08 2010-11-10 株式会社ヤマウラ 玉葱残屑を原料とするケルセチン含有粉末とその製造方法
JP5697834B2 (ja) * 2006-12-20 2015-04-08 グリコ乳業株式会社 ケルセチン生体吸収促進剤
JP2008201763A (ja) * 2007-02-22 2008-09-04 Bull-Dog Sauce Co Ltd 抗酸化組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006014028A1 (ja) 2004-08-06 2006-02-09 Mochida Pharmaceutical Co., Ltd. サツマイモ茎葉抽出物およびその用途
WO2006070856A1 (ja) 2004-12-28 2006-07-06 Suntory Limited セサミン／エピセサミン組成物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109705178A (zh) * 2018-12-28 2019-05-03 贵阳中医学院 一种从小花清风藤中提取的化合物及其提取工艺和应用
CN109705178B (zh) * 2018-12-28 2022-12-27 贵州中医药大学 一种从小花清风藤中提取的化合物及其提取工艺和应用

Also Published As

Publication number Publication date
TWI429430B (zh) 2014-03-11
TW200942234A (en) 2009-10-16
HK1150562A1 (en) 2012-01-06
CN101909619B (zh) 2012-08-29
CA2710379A1 (en) 2009-07-09
SG187399A1 (en) 2013-02-28
NZ586196A (en) 2012-07-27
AU2008344481A1 (en) 2009-07-09
US20100311676A1 (en) 2010-12-09
CA2710379C (en) 2016-04-19
CN101909619A (zh) 2010-12-08
MY153899A (en) 2015-04-15
AU2008344481B2 (en) 2013-05-16
JP2009155312A (ja) 2009-07-16
KR20100103849A (ko) 2010-09-28
WO2009084482A1 (ja) 2009-07-09
JP5276316B2 (ja) 2013-08-28
US8653040B2 (en) 2014-02-18

Similar Documents

Publication Publication Date Title
KR101514860B1 (ko) 세사민류 및 퀘르세틴 배당체를 함유하는 조성물
CN102088970B (zh) 用含槲皮素的组合物在制备改善肾功能的药物中的应用
WO2006074278A2 (en) Compositions for treating diabetes or obesity
WO2006035900A1 (ja) コエンザイムｑ１０含有乳化組成物
US20090143317A1 (en) Quercetin Glycoside Composition and Method of Preparing the Same
JP4995567B2 (ja) セサミン／エピセサミン組成物
CN102264366B (zh) 含有芝麻素类和表没食子儿茶素没食子酸酯的组合物
US8530446B2 (en) Oral composition containing difructose anhydride
US20070298136A1 (en) Cholesterol regulating agent
JPWO2013187391A1 (ja) セサミン類とγ−オリザノールと米胚芽油とを含有する組成物
US20120070487A1 (en) Alkylsaccharide compositions with nutraceuticals
HK1150562B (en) Composition comprising sesamin component and quercetin glycoside
KR101991746B1 (ko) 카테킨 생체 이용률 증진제
HK1161550B (en) Composition containing sesamins and epigallocatechin gallate
HK1107266B (en) Oral composition containing difructose anhydride
HK1204936B (en) Composition comprising sesamin compound, γ-orizanol and rice germ oil

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20230418

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20230418

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000